Union Bancaire Privee UBP SA Takes $6.85 Million Position in Corteva, Inc. $CTVA

Union Bancaire Privee UBP SA purchased a new position in shares of Corteva, Inc. (NYSE:CTVA) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 81,822 shares of the company’s stock, valued at approximately $6,849,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. JPL Wealth Management LLC acquired a new position in Corteva during the third quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC bought a new stake in shares of Corteva in the fourth quarter valued at about $27,000. Bank of Jackson Hole Trust acquired a new stake in shares of Corteva during the 4th quarter worth approximately $28,000. Cornerstone Financial Management LLC acquired a new stake in Corteva during the fourth quarter worth $29,000. Finally, Basepoint Wealth LLC bought a new stake in Corteva in the fourth quarter valued at about $30,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 1.2%

CTVA opened at $82.60 on Friday. The firm’s fifty day moving average is $79.38 and its two-hundred day moving average is $76.20. The firm has a market cap of $55.24 billion, a PE ratio of 48.59, a price-to-earnings-growth ratio of 2.50 and a beta of 0.57. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.63. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter in the prior year, the company earned $1.13 EPS. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s dividend payout ratio is presently 42.35%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CTVA. The Goldman Sachs Group lifted their price target on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, April 14th. Royal Bank Of Canada boosted their price objective on Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. Weiss Ratings upgraded shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. Mizuho lifted their price target on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 15th. Finally, Morgan Stanley increased their price objective on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $88.81.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.